Abiopharma

New Form S-8 - Korro Bio, Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001193125-26-024394 <b>Size:</b> 311 KB

New Form DEFA14A - Lite Strategy, Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0000929638-26-000268 <b>Size:</b> 12 KB

New Form 424B3 - Flora Growth Corp. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001062993-26-000441 <b>Size:</b> 11 KB

New Form SCHEDULE 13G - Repare Therapeutics Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001723643-26-000001 <b>Size:</b> 10 KB

Global Affiliate Spotlight: SWE University of Lagos

New Form SCHEDULE 13D/A - BIODESIX INC <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0000905148-26-000363 <b>Size:</b> 11 KB

New Form SCHEDULE 13G - enGene Holdings Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0002005369-26-000002 <b>Size:</b> 25 KB

📋 GUTHART GARY S (Officer) plans to sell 3K shares of INTUITIVE SURGICAL INC (at $531.52 each, total $1.5M) Filed: Jan 27, 2026 | ID: 000021

New Form D - NovaBay Pharmaceuticals, Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001389545-26-000001 <b>Size:</b> 6 KB

New Form SCHEDULE 13G/A - LUNA INNOVATIONS INC <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0000906304-26-000034 <b>Size:</b> 10 KB

INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Ini

BD to Announce Financial Results for its First Quarter of Fiscal 2026

Waters - Waters Shareholders Approve Combination with BDs Biosciences & Diagnostic Solutions Business

CNS Pharmaceuticals - New Press Release

Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer